BCSI Scientific Advisory Committee

BCSI recruits individuals to be on the Scientific Advisory Committee (SAC) because they are innovators with outstanding stature in the medical care and diagnostics industry. The SAC is responsible for:

  • Reviewing emerging needs within our industries;
  • Assisting in recruitment of internal scientific personnel;
  • Identifying suitable external sites for pre-clinical and clinical evaluations;
  • Reviewing key documents such as patents and publications;
  • Sharing their learned experience and counsel working with regulatory agencies (e.g. DEKRA, FDA, ISO, etc.);

Prior Members of BCSI's Scientific Advisory Committee have included the people below. BCSI is currently in the process of selecting and forming a Scientific Advisory group for 2012.

Sherrill J. Slichter, M.D. Dr. Slichter was educated at the College of Puget Sound, Washington State University and George Washington University. She currently serves as Professor of Medicine, Hematology/ Medicine, at the University of Washington and Director of Platelet Transfusion Research at the Puget Sound Blood Center. Dr. Slichter is on the staff of University Hospital, Harborview Medical Center, Providence Hospital, and the Veterans Affairs Medical Center. She brings over thirty years experience in blood cell analysis, transfusion therapy, and blood center administration, with special value to the fields of platelet storage and clinical evaluation of transfused platelets. She was co-recipient of the 1998 Karl Landsteiner Memorial Award from the American Association of Blood Banks.
Dirk de Korte, Ph.D. Dr. de Korte received his training at the State Universities of Utrecht and Amsterdam, the Netherlands. He currently serves as Manager Research & Development, Sanquin Blood Bank North West and Senior Scientist, Department Blood Cell Research, Sanquin Research. In his research, he has a close collaboration with the Academical Medical Centre Amsterdam (Department of Physiology) and actively involved in the BEST collaborative. He has more than twenty years experience in blood collection, component preparation, leukodepletion, and blood cell storage. He is an expert in evaluation of in vitro quality for platelets and erythrocytes.
Larry Dumont, Ph.D. Dr. Dumont received an M.B.A. from the University of Phoenix, and a Ph.D. in Clinical Sciences from the University of Colorado Health Sciences Center in Denver. He is Assistant Professor of Pathology at Dartmouth Medical School and Director, Cell Labeling Laboratory, Dartmouth-Hitchcock Medical Center. He spent 27 years at GAMBRO BCT in various technical capacities. His current interests are in platelet physiology, in vivo cell survival kinetics, and clinical outcomes in transfusion medicine. He has been actively involved with the Biomedical Excellence for Safer Transfusion Collaborative (BEST) for 14 years, and is currently co-leader of the Clinical Studies Team. Dr. Dumont has been an invited speaker at meetings of the FDA Blood Product Advisory Committee, the U.S. Department of Health & Human Services Advisory Committee on Blood Safety and Availability, the Paul-Erhlich-Institute, and various national and international congresses.